Drug-resistant TB

Other topics in this section

Drug-resistant TB: latest news

Drug-resistant TB resources

  • Multidrug-resistant tuberculosis

    Some strains of tuberculosis have become resistant to some of the standard drugs. These multidrug-resistant (MDR) strains have infected both people with HIV and HIV-negative...

    From: HIV treatments directory

    Information level Level 4

  • Think TB

    TB is one of the major killers in people with HIV. This publication brings together research on the management of TB in people with HIV....

    From: Think TB

    Information level Level 4

  • Drug-resistant TB

    TB that is resistant to isoniazid and rifampicin, and to other drugs as well, is becoming much more common. This is called multidrug-resistant TB (MDR-TB)...

    From: Booklets

    Information level Level 2

Drug-resistant TB features

Drug-resistant TB news from aidsmap

More news

Drug-resistant TB news selected from other sources

  • Study finds vitamin C can kill drug-resistant TB in test-tube

    In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.

    18 hours ago | Eurekalert Inf Dis

  • The ongoing problem of tuberculosis in the UK

    The report of the All-Party Group on Global Tuberculosis gives grounds for optimism; although the task is huge it provides a coherent set of recommendations that can be taken on by a new public health body seeking to demonstrate its leadership and effectiveness. Successfully leading the strategy to eliminate tuberculosis in the UK should be an agreed metric to measure the performance of Public Health England.

    26 April 2013 | The Lancet (editorial)

  • Drug-Resistant Tuberculosis: Old Disease – New Threat

    In a new Report a group of MPs is calling on the UK Government for a two-fold approach to tackling the increasing public health threat of tuberculosis (TB) which is being exacerbated by drug-resistant strains (DR-TB) in all parts of the world, including the UK.

    15 April 2013 | UK All-Party Parliamentary Group on Global Tuberculosis

  • African Health Ministers Commit to Ramped Up TB/HIV Treatment

    Health ministers from Swaziland and South Africa have agreed to radically change the diagnosis and treatment of the co-epidemic of TB/HIV in their countries.

    22 March 2013 | Voice of America

  • The Union offers hope and practical advice on multidrug-resistant tuberculosis

    The Union is marking World TB Day this year by publishing a new guide that offers clear, practical advice on one of the trickiest aspects of "stopping TB" – how to manage the estimated 310,000 patients who have multidrug-resistant TB (MDR-TB).

    21 March 2013 | International Union Against Tuberculosis and Lung Disease

  • Sluggish response risks squandering historic opportunity to tackle global drug-resistant tuberculosis

    If measures to tackle multidrug-resistant tuberculosis (MDR-TB) are not significantly stepped up, including addressing barriers that prevent both research into better drug combinations and treatment scale up, MDR-TB rates will continue to increase worldwide and a historic opportunity to improve abysmal cure rates will have been squandered, medical humanitarian organisation Médecins Sans Frontières (MSF) warned today.

    20 March 2013 | MSF

  • Tuberculosis: Europe’s Ticking Timebomb

    On World Tuberculosis Day the TB Europe Coalition called on the European Commission to substantially increase funding to fight tuberculosis in Europe. Tuberculosis causes not only illness and death, according to estimates, it costs EU Member States €15 million every week and €750 million every year.

    20 March 2013 | TB Europe Coalition

  • World Health Organization and Global Fund cite tuberculosis threat

    WHO and the Global Fund to Fight AIDS, TB and Malaria said today that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at least US$ 1.6 billion in international funding for treatment and prevention of the disease.

    18 March 2013 | World Health Organization

  • Global Drug Facility achieves price reduction for drug-resistant TB treatments

    The Stop TB Partnership’s Global Drug Facility has reduced the price of several second-line drugs it supplies for the treatment of multidrug resistant tuberculosis (MDR-TB) by up to 26% compared to 2011 prices, resulting in a decrease in the overall cost of treatment.

    18 March 2013 | Stop TB Partnership

  • An Activist’s Guide to Bedaquiline (Sirturo)

    Bedaquiline (also known by its trade name, Sirturo, or as TMC207) is the first new drug from a new drug class to treat TB to be approved by the United States Food and Drug Administration (FDA) in over 40 years. This guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward. .

    12 March 2013 | Treatment Action Group
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also